Dr. Robert Su, M.D

NPI: 1932439932
Total Payments
$37,209
2024 Payments
$34,998
Companies
5
Transactions
36
Medicare Patients
2,329
Medicare Billing
$298,601

Payment Breakdown by Category

Other$28,272 (76.0%)
Consulting$5,472 (14.7%)
Travel$2,727 (7.3%)
Food & Beverage$717.89 (1.9%)
Education$19.25 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,272 11 76.0%
Consulting Fee $5,472 3 14.7%
Travel and Lodging $2,727 10 7.3%
Food and Beverage $717.89 11 1.9%
Education $19.25 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $37,132 32 $0 (2024)
MEDAC PHARMA, INC. $22.33 1 $0 (2018)
SOBI, INC $19.25 1 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $18.48 1 $0 (2017)
AbbVie, Inc. $16.86 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $34,998 30 Amgen Inc. ($34,978)
2023 $2,153 3 Amgen Inc. ($2,153)
2018 $22.33 1 MEDAC PHARMA, INC. ($22.33)
2017 $35.34 2 Boehringer Ingelheim Pharmaceuticals, Inc. ($18.48)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/14/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $156.03 General
Category: Inflammation
11/14/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage Cash or cash equivalent $26.59 General
Category: Inflammation
11/13/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,648.00 General
Category: Inflammation
11/13/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,216.00 General
Category: Inflammation
11/13/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $267.90 General
Category: Inflammation
11/13/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage Cash or cash equivalent $22.09 General
Category: Inflammation
11/09/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging In-kind items and services $242.95 General
Category: Inflammation
11/08/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $131.04 General
Category: Inflammation
10/17/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,648.00 General
Category: Inflammation
10/17/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,432.00 General
Category: Inflammation
10/15/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $121.89 General
Category: Inflammation
10/06/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,040.00 General
Category: Inflammation
10/01/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $477.75 General
Category: Inflammation
10/01/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $258.63 General
Category: Inflammation
10/01/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage Cash or cash equivalent $78.85 General
Category: Inflammation
09/27/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging In-kind items and services $278.90 General
Category: Inflammation
09/25/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging In-kind items and services $185.72 General
Category: Inflammation
09/03/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,648.00 General
Category: Inflammation
09/03/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,432.00 General
Category: Inflammation
08/30/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $149.99 General
Category: Inflammation
08/22/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging In-kind items and services $713.60 General
Category: Inflammation
08/20/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,648.00 General
Category: Inflammation
08/20/2024 Amgen Inc. TAVNEOS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $608.00 General
Category: Inflammation
08/20/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $137.00 General
Category: Inflammation
08/20/2024 Amgen Inc. TAVNEOS (Drug) Travel and Lodging Cash or cash equivalent $9.00 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 563 954 $246,778 $72,593
2022 12 587 1,042 $250,408 $78,106
2021 13 581 957 $268,161 $81,889
2020 15 598 905 $234,766 $66,013
Total Patients
2,329
Total Services
3,858
Medicare Billing
$298,601
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 205 327 $119,028 $34,309 28.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 61 89 $43,521 $14,217 32.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 33 33 $23,001 $6,293 27.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 48 62 $15,314 $4,650 30.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 23 23 $12,742 $3,262 25.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 11 14 $9,856 $2,242 22.7%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 28 28 $2,520 $2,123 84.2%
20610 Aspiration and/or injection of fluid from large joint Office 2023 24 29 $8,643 $2,105 24.4%
20600 Aspiration and/or injection of fluid from small joint Office 2023 24 30 $5,978 $1,579 26.4%
G0008 Administration of influenza virus vaccine Office 2023 29 29 $1,885 $1,077 57.1%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Office 2023 14 18 $2,340 $523.32 22.4%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 47 226 $1,582 $189.21 12.0%
J7050 Infusion, normal saline solution, 250 cc Office 2023 16 46 $368.00 $23.29 6.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 189 304 $107,312 $34,341 32.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 79 107 $50,825 $16,998 33.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 41 41 $27,470 $8,430 30.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 38 38 $20,444 $5,532 27.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 51 59 $14,160 $4,439 31.3%
20610 Aspiration and/or injection of fluid from large joint Office 2022 37 52 $12,968 $3,247 25.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 19 19 $1,596 $1,335 83.6%
20600 Aspiration and/or injection of fluid from small joint Office 2022 20 29 $5,452 $1,284 23.6%
G0008 Administration of influenza virus vaccine Office 2022 22 22 $1,430 $804.54 56.3%
20605 Aspiration and/or injection of fluid from medium joint Office 2022 11 15 $3,591 $709.43 19.8%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Office 2022 22 23 $2,829 $686.32 24.3%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 58 333 $2,331 $299.81 12.9%

About Dr. Robert Su, M.D

Dr. Robert Su, M.D is a Internal Medicine healthcare provider based in Fremont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1932439932.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Su, M.D has received a total of $37,209 in payments from pharmaceutical and medical device companies, with $34,998 received in 2024. These payments were reported across 36 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,272).

As a Medicare-enrolled provider, Su has provided services to 2,329 Medicare beneficiaries, totaling 3,858 services with total Medicare billing of $298,601. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Rheumatology
  • Location Fremont, CA
  • Active Since 01/13/2010
  • Last Updated 05/28/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1932439932

Products in Payments

  • TAVNEOS (Drug) $36,220
  • Rasuvo (Drug) $22.33
  • KINERET (Drug) $19.25
  • OFEV (Drug) $18.48
  • Humira (Biological) $16.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Fremont